Agrylin

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 54092-063
  • Package NDC 54092-063-01
  • Application number NDA020333
  • SPL ID 80829f8c-c5ee-4e37-b5af-1b0e4e4dd5bd
  • SPL set ID cb960074-99c1-4a73-941f-f0644a7ec219
  • UNII VNS4435G39
  • RxCUI 597850
  • RxCUI 597857

What the source publishes

Labeler
Takeda Pharmaceuticals America, Inc.
Active ingredients
anagrelide hydrochloride
Form
CAPSULE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:54092-063_80829f8c-c5ee-4e37-b5af-1b0e4e4dd5bd
{
  "name": "Agrylin",
  "splId": "80829f8c-c5ee-4e37-b5af-1b0e4e4dd5bd",
  "labels": [
    {
      "setId": "cb960074-99c1-4a73-941f-f0644a7ec219",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cb960074-99c1-4a73-941f-f0644a7ec219",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cb960074-99c1-4a73-941f-f0644a7ec219"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Takeda Pharmaceuticals America, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "100 CAPSULE in 1 BOTTLE (54092-063-01)",
      "package_ndc": "54092-063-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "19970314"
    }
  ],
  "productId": "54092-063_80829f8c-c5ee-4e37-b5af-1b0e4e4dd5bd",
  "useDomain": "unknown",
  "dosageForm": "CAPSULE",
  "productNdc": "54092-063",
  "deaSchedule": null,
  "genericName": "anagrelide hydrochloride",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "ANAGRELIDE HYDROCHLORIDE ANHYDROUS",
      "strength": ".5 mg/1"
    }
  ],
  "applicationNumber": "NDA020333",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "19970314",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0354092063017"
    ],
    "unii": [
      "VNS4435G39"
    ],
    "rxcui": [
      "597850",
      "597857"
    ],
    "spl_set_id": [
      "cb960074-99c1-4a73-941f-f0644a7ec219"
    ],
    "manufacturer_name": [
      "Takeda Pharmaceuticals America, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:54092-063_80829f8c-c5ee-4e37-b5af-1b0e4e4dd5bd"